心臓不整脈モニタリング装置の世界市場：2024-2031年

世界の心臓不整脈モニタリング装置市場規模、シェア、動向分析レポート：装置タイプ別（イベントモニタリング装置、連続リズムモニタリング装置、ホルターモニタリング装置）、サービスプロバイダ別（モバイル心臓テレメトリモニタリングサービスプロバイダ、独立診断検査施設/クリニック）予測期間（2024-2031年）

世界の心臓不整脈モニタリング装置市場は、予測期間中にCAGR7.5%の大幅な成長が見込まれます。心房細動（AF）の世界の発生率と有病率の増加が、心臓不整脈モニタリング装置の需要を促進し、それによって世界市場の成長を牽引しています。米国だけでも300万から600万人が心房細動を患っており、その数は2050年までに約600万から1,600万人に達すると予測されています。欧州では、2010年の55歳以上の心房細動有病者数は約900万人で、2060年には1,400万人に達すると予測されています。アジアでは、2050年までに少なくとも7,200万人が心房細動と診断され、約300万人が心房細動に関連した脳卒中と診断されると推定されています。高齢者人口は心房細動のリスクが高いです。世界保健機関の2021年10月の報告書によると、世界の60歳以上の高齢者人口は2020年の10億人から2050年には21億人に増加すると予想されており、高齢者が介護やその他のニーズを他者に依存する傾向が強まるため、在宅医療ソフトウェア市場の需要に大きな影響を与えることが予想されます。

高齢者人口の増加は、世界市場の需要をさらに後押ししています。2024年1月、リトアニアの2つの大学の研究者が、心房細動を誘発する個々の要因を特定し管理する、患者に安全なモニタリング技術を開発しました。この技術は、カウナス工科大学生体医工学研究所（KTU BMEI）とヴィリニュス大学（VU）サンタロスクリニックの共同研究の成果です。心房細動監視装置の分野で進行中の研究は、市場開拓をさらに後押ししています。可搬型でモニタリングが容易な装置の開拓は、世界市場の成長に有利な機会を提供すると予想されます。モニタリング装置のコストが高いことが、市場の成長を抑制する可能性があります。

セグメント別展望

ホルターモニタリング装置が世界の心臓不整脈モニタリング装置市場で顕著な成長を遂げる見込み

これらの装置は、患者の散発的な症状を診断する際に長時間使用できることが、市場の需要拡大に大きく寄与しています。また、患者のコンプライアンスを高め、治療成績を向上させるために、より迅速で便利なモニタリングを提供します。このカテゴリーの新製品発売は、この市場セグメントの成長をさらに後押ししています。例えば、2021年2月、RhythMedixは不整脈検出用のウェアラブル心臓モニターを発売しました。RhythMedixは、この一体型装置はホルターモニタリングを提供し、より良い患者ケアのために患者と臨床医をつなぐ初のウェアラブルマルチモダリティ心臓モニターであると述べています。

地域別展望

世界の心臓不整脈モニタリング装置市場は、北米（米国とカナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋（インド、中国、日本、韓国、その他）、世界のその他の地域（中東・アフリカ、ラテンアメリカ）の地域別にさらに細分化されます。アジア太平洋は、世界市場でかなりの成長を示すと予想されています。

北米が世界市場で大きなシェアを占める

同地域の市場シェアは、不整脈の有病率が高く、高度なヘルスケアインフラが整っていることに起因しています。心房細動は、しばしばAFibまたはAFと呼ばれ、治療される心臓不整脈の中で最も一般的なタイプです。米国疾病予防管理センターによると、2019年、米国ではAFibが原因で183,321人が死亡しました。2030年には米国で1,210万人がAFibに罹患すると推定されています。高いヘルスケア支出とともに、高度なモニタリング装置が容易に入手可能であることが、地域市場シェアにさらに寄与しています。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Abbott Laboratories
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• ACSDiagnostics
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• GE Healthcare
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Koninklijke Philips NV
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 心臓不整脈モニタリング装置の世界市場：装置タイプ別
  • イベントモニタリング装置
  • 連続リズムモニタリング装置
  • ホルターモニタリング装置
• 心臓不整脈モニタリング装置の世界市場：サービスプロバイダ別
  • モバイル心臓テレメトリーモニタリングサービスプロバイダ
  • 独立診断検査施設/クリニック

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 世界のその他の地域

第6章 企業プロファイル

• AliveCor Inc.
• Applied Cardiac Systems
• Biotricity
• Biotronik
• BPL Medical Technologies
• Fukuda Denshi Co. Ltd.
• HD Medical Inc.
• HemoCath Ltd.
• iRhythm Technologies Inc.
• Medi-Lynx Cardiac Monitoring LLC
• Medtronic PLC
• Moving Analytics Inc.
• Nihon Kohden Corp.
• Progetti SRL
• SpaceLabs Healthcare（OSI Systems, Inc.）
• Spacelabs Healthcare Inc.
• Welch Allyn, Inc.

LIST OF TABLES

• 1.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
• 2.GLOBAL EVENT MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 3.GLOBAL CONTINUOUS RHYTHM MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 4.GLOBAL HOLTER MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 5.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
• 6.GLOBAL MOBILE CARDIAC TELEMETRY MONITORING SERVICE PROVIDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 7.GLOBAL INDEPENDENT DIAGNOSTIC TESTING FACILITIES/CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 8.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
• 9.NORTH AMERICAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 10.NORTH AMERICAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
• 11.NORTH AMERICAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
• 12.EUROPEAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 13. EUROPEAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
• 14.EUROPEAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
• 15.ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 16.ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
• 17.ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)
• 18.REST OF THE WORLD CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
• 19.REST OF THE WORLD CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023-2031 ($ MILLION)
• 20.REST OF THE WORLD CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023-2031 ($ MILLION)

LIST OF FIGURES

• 1.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY DEVICE TYPE, 2023 VS 2031 (%)
• 2.GLOBAL EVENT MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 3.GLOBAL CONTINUOUS RHYTHM MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 4.GLOBAL HOLTER MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 5.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY SERVICE PROVIDER, 2023 VS 2031 (%)
• 6.GLOBAL MOBILE CARDIAC TELEMETRY MONITORING SERVICE PROVIDERS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 7.GLOBAL INDEPENDENT DIAGNOSTIC TESTING FACILITIES/CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 8.GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
• 9.US CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 10.CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 11.UK CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 12.FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 13.GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 14.ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 15.SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 16.REST OF EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 17.INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 18.CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 19.JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 20.SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 21.REST OF ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 22.LATIN AMERICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)
• 23.THE MIDDLE EAST AND AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SIZE, 2023-2031 ($ MILLION)

Global Cardiac Arrhythmia Monitoring Devices Market Size, Share & Trends Analysis Report by Device Type (Event Monitoring Devices, Continuous Rhythm Monitoring Devices, and Holter Monitoring Devices), and by Service Provider (Mobile Cardiac Telemetry Monitoring Service Providers, Independent Diagnostic Testing Facilities/Clinics) Forecast Period (2024-2031)

The global cardiac arrhythmia monitoring devices market is anticipated to grow at a considerable CAGR of 7.5% during the forecast period. The growing incidence and prevalence of atrial fibrillation (AF) globally has driven the demand for cardiac arrhythmia monitoring devices thereby driving the global market growth. In the US alone, 3 to 6 million people have AF, and the numbers are projected to reach approximately 6 to 16 million by 2050. In Europe, prevalent AF in 2010 was approximately 9 million among individuals older than 55 years and is expected to reach 14 million by 2060. It was estimated that by 2050 AF will be diagnosed at least in 72 million individuals in Asia, with approximately 3 million with AF-related strokes. The geriatric population is highly at risk of having AF. According to the October 2021 report of the World Health Organization, the global population of people aged 60 years and more is expected to increase from 1 billion in 2020 to 2.1 billion by 2050, which is expected to have a significant impact on the demand for home healthcare software market as older people are more dependent upon others for their care and other needs.

The growing geriatric population is further aiding to the demand for the global market. In January 2024, researchers from two Lithuanian universities have developed a patient-safe monitoring technology to identify and manage individual factors provoking atrial fibrillation. The technology is a result of a collaboration between Kaunas University of Technology Biomedical Engineering Institute (KTU BMEI) and Vilnius University (VU) Santaros Clinics. The ongoing researches in the field of AF monitoring devices are further aiding to the market development. The development of portable and easy to monitoring devices is anticipated to offer lucrative opportunities to the growth of the global market. The high cost of monitoring device may restrain their market growth.

Segmental Outlook

The global cardiac arrhythmia monitoring devices market is segmented based on device type, and service provider. Based on device type, the market is segmented into event monitoring devices, continuous rhythm monitoring devices, and Holter monitoring devices. Based on service providers, the market is segmented into mobile cardiac telemetry monitoring service providers, and independent diagnostic testing facilities/clinics.

Holter Monitoring Devices Anticipated to Exhibit Considerable Growth in the Global Cardiac Arrhythmia Monitoring Devices Market

The ability of these devices to be used for longer durations in diagnosing sporadic symptoms among patients is a key contributor to its growing market demand. They also offer faster and more convenient monitoring to increase patient compliance and enhance treatment outcomes. New product launches in this category are further aiding the growth of this market segment. For instance, in February 2021, RhythMedix launched a wearable cardiac monitor for arrhythmia detection. RhythMedix stated that the one-piece device is the first wearable multi-modality cardiac monitor offering Holter monitoring and connecting patients and clinicians for better patient care.

Regional Outlook

The global cardiac arrhythmia monitoring devices market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit considerable growth in the global market.

North America Held a Major Share in the Global Market

The regional market share is attributed to the high prevalence of arrhythmia and the availability of advanced healthcare infrastructure. Atrial fibrillation, often called AFib or AF, is the most common type of treated heart arrhythmia. According to the Centers for Disease Control & Prevention, in 2019, 183,321 mortalities occurred in the US due to AFib. It is estimated that 12.1 million people in the US will have AFib in 2030. The easy availability of advanced monitoring devices along with high healthcare expenditure is further contributing to the regional market share.

Market Players Outlook

The major companies serving the global cardiac arrhythmia monitoring devices market include Abbott Laboratories, Medtronic PLC, ACSDiangostics, GE Healthcare, and Koninklijke Philips NV among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and advancement in their product offerings to stay competitive in the market. For instance, in October 2023, Boston Scientific received FDA clearance and launched its next-generation insertable cardiac monitor for long-term monitoring of arrhythmias associated with atrial fibrillation, cryptogenic stroke, and syncope. The system (LUX-Dx II+) is designed with algorithms to detect and verify arrhythmias before sending an alert to clinicians and allows patient care teams to adjust event detection settings remotely and record symptoms without in-person visits, according to a company email sent to Healio.

The Report Covers:

• Market value data analysis of 2023 and forecast to 2031.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global cardiac arrhythmia monitoring devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1.Research Methods and Tools
• 1.2.Market Breakdown
  • 1.2.1.By Segments
  • 1.2.2.By Region

2.Market Overview and Insights

• 2.1.Scope of the Report
• 2.2.Analyst Insight & Current Market Trends
  • 2.2.1.Key Findings
  • 2.2.2.Recommendations
  • 2.2.3.Conclusion

3.Competitive Landscape

• 3.1.Key Company Analysis
• 3.2.Abbott Laboratories
  • 3.2.1.Overview
  • 3.2.2.Financial Analysis
  • 3.2.3.SWOT Analysis
  • 3.2.4.Recent Developments
• 3.3.ACSDiagnostics
  • 3.3.1.Overview
  • 3.3.2.Financial Analysis
  • 3.3.3.SWOT Analysis
  • 3.3.4.Recent Developments
• 3.4.GE Healthcare
  • 3.4.1.Overview
  • 3.4.2.Financial Analysis
  • 3.4.3.SWOT Analysis
  • 3.4.4.Recent Developments
• 3.5.Koninklijke Philips NV
  • 3.5.1.Overview
  • 3.5.2.Financial Analysis
  • 3.5.3.SWOT Analysis
  • 3.5.4.Recent Developments
• 3.6.Key Strategy Analysis

4.Market Segmentation

• 4.1.Global Cardiac Arrhythmia Monitoring Devices Market by Device Type
  • 4.1.1.Event Monitoring Devices
  • 4.1.2.Continuous Rhythm Monitoring Devices
  • 4.1.3.Holter Monitoring Devices
• 4.2.Global Cardiac Arrhythmia Monitoring Devices Market by Service Provider
  • 4.2.1.Mobile Cardiac Telemetry Monitoring Service Providers
  • 4.2.2.Independent Diagnostic Testing Facilities/Clinics

5.Regional Analysis

• 5.1.North America
  • 5.1.1.United States
  • 5.1.2.Canada
• 5.2.Europe
  • 5.2.1.UK
  • 5.2.2.Germany
  • 5.2.3.Italy
  • 5.2.4.Spain
  • 5.2.5.France
  • 5.2.6.Rest of Europe
• 5.3.Asia-Pacific
  • 5.3.1.China
  • 5.3.2.India
  • 5.3.3.Japan
  • 5.3.4.South Korea
  • 5.3.5.Rest of Asia-Pacific
• 5.4.Rest of the World

6.Company Profiles

• 6.1.AliveCor Inc.
• 6.2.Applied Cardiac Systems
• 6.3.Biotricity
• 6.4.Biotronik
• 6.5.BPL Medical Technologies
• 6.6.Fukuda Denshi Co. Ltd.
• 6.7.HD Medical Inc.
• 6.8.HemoCath Ltd.
• 6.9.iRhythm Technologies Inc.
• 6.10.Medi-Lynx Cardiac Monitoring LLC
• 6.11.Medtronic PLC
• 6.12.Moving Analytics Inc.
• 6.13.Nihon Kohden Corp.
• 6.14.Progetti SRL
• 6.15.SpaceLabs Healthcare (OSI Systems, Inc.)
• 6.16.Spacelabs Healthcare Inc.
• 6.17.Welch Allyn, Inc.